FDA Inspection 578402 — Innovative Blood Resources

Innovative Blood Resources — FEI 2177724

The FDA completed an inspection of Innovative Blood Resources on Apr 21, 2009 in Duluth, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 1 citation was issued during this inspection. Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Apr 21, 2009
Fiscal Year
2009
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Duluth, MN (United States)

Citations

IDCFRDescription
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.